宅宅网在线电影观看神奇影院手机版补辫辫下载冲多特软件
细节方面，英力士掷弹兵特别版车型带有圆形日行灯、大灯保护罩、车尾爬梯、外挂式备胎、18英寸锻造合金轮辋以及车身多处专属标识。配色方面，该车提供岩浆红、白蓝、风暴绿和风暴银四种可选。
2024年12月09日，乐山这10家酒店民宿，冬天一定要去睡一晚！2023-11-28 17:12·乐山文广旅游局冬游乐山，玩法多多吃美食、看大佛、泡温泉、滑雪...或者就在市区来一场City walk亦或去周边度过一个完美周末这份民宿/酒店清单可别错过赶紧放入收藏夹！市中区篇禅驿·嘉定院子禅驿·嘉定院子坐落于嘉定坊的尽头，一条岷江河将民宿与乐山城区分成两边。水流潺潺，临水而建的民宿背靠凌云山，环抱一片碧水，回首可见清澈的水流，抬头可见蜿蜒的山峦。图 / 恒旅网初冬的禅驿，在嘉定坊的金黄银杏笼罩下安然静卧。落叶缤纷、抄书饮茶、参禅礼佛、品味素食...院子里的美好生活正在徐徐展开。图 / 乐山大佛景区电话 : 0833-2178668地址 : 四川省乐山市中区凌云路嘉定坊嘉庆关内顺城212轻奢民宿大隐隐于市，乐山老城区市中心的顺城街拱宸门旁，一座悠然安静、韵味十足的民国风小院伫立于此。这里便是以街道命名的民宿——顺城212轻奢民宿。图 / 新乐山民宿设有茶咖，可以喝茶、聊天、办公，一楼还准备有旗袍，住店客人可以免费体验旗袍秀。楼上便是舒适的客房，每一间房的门牌号都不一样——“铜河”“平羌”“育贤”象征意义大不相同，房间布置也各具特色。这里离上中顺特色街区也很近，傍晚慢慢踱步到江边，吹吹晚风、看看夜景，属实惬意。图 / 新乐山电话 : 0833-3518222地址 : 四川省乐山市市中区顺城街212号近上中顺、古街乐山岩栖民宿岩栖民宿离市区很近，开车10分钟，就能享受山水间的自在宁静，又能感慨与现代交错的繁华。图 / 岩栖民宿民宿建立在红砂崖下，如同住在原始森林里面，砖红色的岩石墙壁，碧绿的数木栖息而立，沿着小道前行，有种“曲径通幽处”的感觉，像是误入一方不能被打扰的私家花园。冬天栖在「岩栖」，可以体验建造在自然洞穴里建造的洞穴私汤池，非常特别。还能日观大佛、夜游三江，打卡网红地标嘉定坊，更有乐山特色美食一站式直享。图 / 岩栖民宿电话 : 0833-2300195地址 : 四川省乐山市市中区凌云路12号秋叶山居民宿非常田园风的一间民宿，位置靠近绿心公园。庭院雅致舒适，房间布置得很有格调，从园林环境到室内外陈设，包括洗漱用品都很讲究，能看出民宿主人的用心。图 / 小红书、商家美团民宿的环境用一句诗形容便是“曲径通幽处”，是名副其实的闹中取静。清晨，在鸟语花香中醒来；下午，在阳光书房中发呆；夜晚，在万籁俱静中入梦。图 / 商家美团地址：市中区东坡路绿缘小区西北侧约450米枕山?栖谷民宿位于嘉州长卷·天街的一家精品民宿，偏洞穴的风格贴合“栖息在山谷”的韵味，每一个院落都有着独特的景致。图 / 商家美团房型名字也很有特色：丘云、雨歇、倚蓬、芦花、野渡...极尽文艺，也极富诗意。早上醒来听着山林间的鸟鸣，看着窗外涌动的岷江，再多疲劳也能褪去。这里出行也方便快捷，十分钟车程便可抵达市区寻觅美食。图 / 商家美团地址：市中区碧山路1819号电话：0833-2129988睡樂民宿睡樂位于乐山老城区，环境非常小清新。老中式院落的简约，没有拥挤的人群，远离了尘世的喧嚣。房间也是极简风格，清爽干净。图 / 商家美团这里能感受老嘉州的风土人情，出门几步路就能远眺乐山大佛，到东大街、上中顺街区品尝美食也方便得很。图 / 商家美团地址：市中区较场坝街169号电话：18148084676其他区县篇峨眉山御泉湾酒店看名字就知道这是一家以温泉为特色的酒店。坐落于峨眉山景区，紧邻4A级峨秀湖公园，与“天下名山”牌坊零距离。图 / 峨眉山御泉湾酒店酒店以禅文化为轴心，打造室内外温泉池40多个，可以同时容纳上千人，是西南少有的大型温泉群。汤池以“春夏秋冬”四季风采为主题，将春的温馨、夏的狂热、秋的成熟。冬的纯洁以自然生态的养生理念进行了精心打造。图 / 峨眉山御泉湾酒店电话 : 0833-5026666地址 : 四川省乐山市峨眉山市温泉大道333号雷洞烟云·星空营地坐落在海拔2400米的雷洞坪滑雪场内，整个乐园占地15亩，距离山顶“一步之遥”，绝佳的地理位置和超棒的自然环境，隔绝了都市的喧嚣，却又能体会最城市的“生活”。图 / 雷洞烟云·星空营地这个时节到营地，只见周围皆是皑皑白雪。每天下午15:00，营地都会组织住宿客人到雷洞坪周边走走、看看、听听。如果你只想在这里独处一番，营地接待中心还为你准备书籍，可以在木屋帐篷里，泡一壶茶，沉浸在与作者的思想交流中。另外，备受期待的峨眉山滑雪场也即将开放，敬请期待！图 / 雷洞烟云·星空营地滑雪团队、研学合作咨询：0833-5098025营地住宿咨询：0833-5525699黑竹沟温泉山庄冬日黑竹沟的魅力就在于不同的天气便能让你看到不一样的景色。晴天雪后的天空会更加湛蓝，就像是一张蓝色幕布一样，衬得山上的雪格外的白。图 / 黑竹沟景区北纬30°赋予了黑竹沟神秘的面纱，也赠予黑竹沟得天独厚的地热资源，使得黑竹沟具有丰富的温泉资源。冬天来黑竹沟，在景区赏完绝美的雪景后，想寻一处放松之地，那黑竹沟温泉山庄再合适不过了！图 / 峨边在线电话 : 0833-5280188地址 : 四川峨边金岩乡温泉村卡莎莎乡村度假区冬日马边，也有好风景。当绿了一年的山谷铺满洁白，当光秃的枝桠覆上冰晶，当雪中的茶山被红色点缀，远远看去便是一幅天然水墨画。图 / 今日马边在室外玩爽了，就回院里暖一暖吧。在卡莎莎乡村度假区，有暖和的温泉和特色彝家菜肴，还能到后山茶田采茶花，以及森林徒步、茶山祈福、篝火晚会等多种冬趣！图 / 卡莎莎乡村度假区卡莎莎目前有7套特色小院与4栋树屋，每个房间都有配备空调以及地暖。配套1个带多媒体空间的游客中心、1间可容纳60人用餐的餐厅、1间售卖农副产物的小卖店、1条可供放空的茶廊、1间精神空间，可满足多种需求哟~图 / 卡莎莎乡村度假区地址：四川省乐山市马边彝族自治县劳动镇福来村6组电话：18383381718信息来源：恒旅网
宅宅网在线电影观看神奇影院手机版补辫辫下载冲多特软件
4、英国央行官员警告称利率上升增加了市场再次遭受冲击的风险
除此之外，齿厂搁-155还配备了现代圆形液晶仪表盘、尝贰顿大灯组、尝贰顿转向灯等多种实用功能，为骑行者提供了更加便捷舒适的使用体验。这款车的车身尺寸也非常适中，无论是男性车友还是女性车友，都能够得到非常好的驾驶控制感，满足他们对于时尚潮流的追求。在杨凯生看来，商业银行可从多方面发力。一是在服务对象上，要努力前移服务重心，推动科创金融服务专项行动，重点支持基础研究和底层技术创新。同时也要加大对初创期、成长期科创公司的服务力度，围绕国家级高新区积极开展银政、银企合作，为相关机构和公司提供长期资金支持。
测辞耻肠颈濒补颈办补苍飞辞驳耻辞诲别箩颈补苍蝉丑别，丑耻补苍蝉丑颈蹿别颈肠丑补苍驳诲别蹿补诲补，产耻箩颈苍驳耻辞苍别颈诲别箩颈补苍蝉丑别，飞辞尘别苍诲别办别箩颈测别测耻别濒补颈测耻别蹿补诲补。办补辞蝉丑补苍驳丑补辞诲补虫耻别，肠丑别苍驳飞别颈迟补产耻苍别苍驳蹿补苍驳辩颈诲别尘耻产颈补辞。
首(Shou)发(Fa)2024-07-16 11:16·张(Zhang)医(Yi)生(Sheng)健(Jian)康(Kang)杂(Za)谈(Tan)
linbaliu | WHOdi5banlinbazuzhizhongliufenlei(zhongyingduizhaozuiquanzuishiyong)yuanchuang2023-07-05 20:58·zhongliuzhuankeyisheng2022nianshijieweishengzuzhi（WHO）fabudi5banzaoxueyulinbazuzhizhongliufenlei（WHO-HAEM5）The 5th edition of the WHO Calssification of Haematolymphoid Tumorsyi、suixizengzhihezhongliubaokuokelongxingzaoxue、gusuizengzhixingzhongliu（manxingsuixibaobaixuebing、manxingzhongxinglixibaobaixuebingdeng）、gusuizengshengyichangzhongliu（MDS）、jixingsuixibaixuebing（AML）dengdeng，tongchangguishuxueyeneike。er、shutuxibao/zuzhixibaozhongliushutuxibao/zuzhixibaozhongliuzaixinbanfenleitixizhongdingweiyusuixizhongliuzhihou，tongchangrenweitamenqiyuanxiangjin，qiyuanyuchangjiandesuixizuxibao（chanshengdanhexibao/zuzhixibao/shutuxibaopuxi），disibanfenleizhong“zuzhixibao/shutuxibaozhongliu”xiade“lvpaoshutuxibaorouliu”、“xianweimuxibaowangzhuangxibaozhongliu”shiyoulinbajizhixibaochanshengdezhongliu，diwubanfenleijiangqifenchulaiguidao“linbazuzhijianzhiyuanxingzhongliu”xia。san、Bxibaolinbazengzhixingjibinghezhongliusi、TheNKxibaolinbazengzhixingjibinghezhongliuwu、linbazuzhijianzhiyuanxingzhongliu（xinyinrufenlei）shuyulinxizhongliu（linbazuzhizhongliu），benwenzhuyaoshejizhesanbufenneirong。liu、yichuanzhongliuzonghezheng（xinyinruzhangjie）yichuanzhongliuzonghezhengbaokuoyihuansuixizhongliuhelinxizhongliuxiangguandezonghezheng。yichuanxingzhongliuzonghezheng（yichuanyiganzonghezheng）xixinyinrudefenlei，baokuofankenipinxue（Fanconipinxue）、bulumuzonghezheng（Bloomzonghezheng，mianbuhongbanzuoruzonghezheng）、gongjishidiaomaoxixueguankuozhangzonghezheng（AT）、RASbing（RASzonghezheng）、Nijmegen-Breakagezonghezheng（Nijmegenduanliezonghezheng，Nijmegen breakage syndrome，NBS）deng。yihuansuixizhongliudeyichuanxingzhongliuzonghezheng：Fanconipinxue、RASbingdeng，ATheNBSzeyulinxizhongliuyouweixiangguan，fenbieyuATMheNBNpeixitubianxiangguan。guanyudi5banfenleidejidianzhongyaoshuoming：1、jibingfencengmuluhejiegouzunzhaoguigejibiedizengdeshunxu，yimuliaoran：leibiecategory（biru：chengshuBxibaolinbaliu）、jiazu/zhongleifamily/class（biru：daBxibaolinbaliu）、shiti/leixingentity/type（biru：mimanxingdaBxibaolinbaliu、feitezhixing）heyaxingsubtype（biru：mimanxingda B xibaolinbaliu，feitezhixing，shengfazhongxinBxibaoyang）。2、jibingfenleizunzhaoxibaopuxideshunxu（puxideguishuyijuliushixibaoshuhe/huomianyizuhuademianyibiaoxingfenxi），xianshiqiantixibaozhongliu，ranhoushichengshuexingzhongliu。zaiyigejiazu/zhonglei（family/class）zhong，shiti/leixing（entity/type）tongchangancongduoxingdaoqinxixingshunxupailie。3、linbaliuyangjibing（yejiushiyulinbaliulinchuangtezhengxiangsidejibing）yijixuyaojianbiedefeizhongliujibingshoucinarufenleizhong，youzhuyufangzhilinbaliuguoduzhenduanbingtigaoduilinchuangbinglixuebutongjibingleixingdeshibie。4、yinrupeixizhongliuyiganzonghezhengzuoweizhuanmendedanjie，yitixianqiriyizengjiadelinchuangzhongyaoxing，zhexiezonghezhengtongchangyusuixihuolinxizhongliuxiangguan。5、duixiantianxing（yuanfaxing）mianyiquexianhehuodexing（jifaxing）mianyijibingxiangguandelinbazengzhiyeyouxindefaxian，duizhexiegengxindeneirongyebaohanzaidiwubanxinfenleizhong。2022 niandiwuban WHO linbazuzhizhongliufenlei：zaoxueyulinbazuzhizhongliufenlei （WHO-HAEM5）linxizhongliubufen：The 5th edition of the WHO Calssification of Haematolymphoid Tumors-Lymphoid Neoplasmaslinbazuzhizhongliu（heji125geshiti/leixing）yi、Bxibaolinbazengzhixingjibinghezhongliu（3leibie，79geshiti/leixing）1、Bxibaoweizhudezhongliuyangbingbian（5ge）2、qiantiBxibaozhongliu（13ge）3、chengshuBxibaozhongliu（49ge）4、jiangxibaozhongliujiqitajuyoufudanbaidejibing（12ge）er、TheNKxibaolinbazengzhixingjibinghezhongliu（3leibie，39geshiti/leixing）1、Txibaoweizhudezhongliuyangbingbian（3ge）2、qiantiTxibaozhongliu（2ge）3、chengshuTheNKxibaozhongliu（34ge）san、linbazuzhijianzhiyuanxingzhongliu（7geshiti/leixing）xiabiaozhongzuocebian2022niandiwubanWHO-HAEM5fenlei（linxi），youcewei2017niandisibanxiudingWHO-HAEM4Rfenlei（linxi）。zhu：lymphoproliferative disorder（LPD），linba（zuzhi）zengshengxingjibing，linba（zuzhi）zengzhixingjibing。BxibaolinbazengzhixingjibinghezhongliuB-cell lymphoid proliferations and lymphomas（79geshiti/leixing）Bxibaoweizhuzhongliuyangbingbian（5geshiti/leixing）Tumor-like lesions with B-cell predominancediwubanfenleidisiban（xiuding）fenleiyulinbaliuxiangsi（linbaliuyang）fanyingxingfuhanBxibaodelinbaxibaozengzhijibing（fuhanBxibaodefanyingxinglinbayangzengsheng，kemonilinbaliu）?Reactive B-cell rich lymphoid proliferations that can mimic lymphomawu（disibanweilieru，bubaokuozainei，xiatong）IgG4xiangguanjibing?IgG4-related diseasewudanzhongxinCastlemanbing?Unicentric Castleman disease（UCD）wutefaxingduozhongxinCastlemanbing（tefaxingMCD）?Idiopathic multicentric Castleman diseasewuKSHV/HHV8 xiangguandeduozhongxinCastlemanbing（KSHV/HHV8xiangguandeMCD）?KSHV/HHV8-associated multicenrtric Castleman diseaseduozhongxinCastlemanbing（MCD）【zhu】Bxibaoweizhuzhongliuyangbingbianxidiwubanxinyinrudefenlei，baokuo5gebutongdejibingshiti/leixing：（1）yiBxibaoweizhudefeizhongliuxinglinbaxibaozengsheng（shejilinbajiehe/huojiewaibuwei），yulinbaliuxiangsi（linbaliuyang），yechengweifuhanBxibaodefanyingxinglinbayangzengsheng，kemonilinbaliu?。gaileijibingbaokuo：shengfazhongxindejinxingxingzhuanhua、chuandan（chuanranxingdanhexibaozengduozheng）、nvxingshengzhidaodecaihuayangfanyingxinglinbazuzhizengsheng/linbaliuyangbingbian、xitongxinghongbanlangchuang。（2）IgG4xiangguanjibing?：IgG4xiangguanlinbajiezhongdajuyouyuCastlemanbingxiangzhongdiedetezheng。（3）Castlemanbingbaokuosanzhongleixing：danzhongxinCastlemanbing?、tefaxingduozhongxinCastlemanbing?、KSHV/HHV8 xiangguandeduozhongxinCastlemanbing?，tamendelinchuanghebinglixuetezhengbutong。qiantiBxibaozhongliu（13geshiti/leixing）Precursor B-cell neoplasmsji：yuanshiBlinbaxibaobaixuebing/linbaliu（Blinbaxibaobaixuebing/linbaliu，Blinbamuxibaobaixuebing/linbaliu，B-cell lymphoblastic leukaemias/lymphomas，B-ALL/LBL）：（1）Blinbamuxibaobaixuebing/linbaliu，feitezhixing（B-ALL/LBL，NOS）（2）bandingyiyichuanxueyichangdeBlinbaxibaobaixuebing/linbamuxibaolinbaliu（12ge）diwubanfenleidisiban（xiuding）fenleiBlinbaxibaobaixuebing/linbaliu，feitezhixing（B-ALL/LBL，NOS）?B-cell lymphoblastic leukaemia/lymphoma，NOSxiangtongbandingyiyichuanxueyichangdeBlinbaxibaobaixuebing/linbamuxibaolinbaliu（12zhong）Blinbaxibaobaixuebing/linbaliu（B-ALL/LBL），bangaochaoerbeiti?B-ALL/LBL with high hyperdiploidyBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），banchaoerbeitiBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），banyaerbeiti（dierbeiti）?B-ALL/LBL with hypodiploidyxiangtongBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），baniAMP21?B-ALL/LBL with iAMP21xiangtongBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），ban BCR::ABL1 ronghe?B-ALL/LBL with BCR::ABL1 fusionBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL）bant(9;22)(q34;q11.2); BCR-ABL1rongheBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），ban BCR::ABL1 yangtezheng?B-ALL/LBL with BCR::ABL1-like featuresBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL）, banBCR-ABL1 yangBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），ban KMT2A zhongpai?B-ALL/LBL with KMT2A rearrangementBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），ban t(v;11q23.3); KMT2AzhongpaiBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），ban ETV6::RUNX1 ronghe?B-ALL/LBL with ETV6::RUNX1 fusionBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），ban t(12;21)(p13.2;q22.1); ETV6-RUNX1rongheBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），ban ETV6::RUNX1yangtezheng?B-ALL/LBL with ETV6::RUNX1-like featureswuBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），ban TCF3::PBX1 ronghe?B-ALL/LBL with TCF3::PBX1 fusionBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），ban t(1;19)(q23;p13.3); TCF3-PBX1rongheBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），ban IGH::IL3 ronghe?B-ALL/LBL with IGH::IL3 fusionBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），ban t(5;14)(q31.1;q32.1); IGH/IL3rongheBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），ban TCF3::HLF ronghe?B-ALL/LBL with TCF3::HLF fusionwuBlinbaxibaobaixuebing/linbaliu（B-ALL/LBL），banqitatedingyichuanxueyichang?B-ALL/LBL with other defined genetic abnormalitiesxiangtong【zhu】B-ALL/LBLfabingjizhizaidaduoshuqingkuangxiacunzaiyizhidequdongyinsu，baokuoiAMP21、BCR::ABL1 ronghe、 KMT2A zhongpai、ETV6::RUNX1 ronghe、TCF3::PBX1 ronghe、 IGH::IL3 ronghe、TCF3::HLF ronghedeng。genjuransetishumubianhua（chaoerbeiti、yaerbeitideng）、ransetizhongpaihuocunzaiqitayichuanqudongyinsuerguiweibutongdeyaxing?-?。genjurenleijiyinzuzuzhijiyinmingmingweiyuanhuijianyi，caiyongshuangmaohao（::）biaojironghejiyinxinmingcheng。chucizhiwaijibianjingguoquanmianjianceyerengranwufafenleideyileijibingzeguiweiBlinbaxibaobaixuebing/linbamuxibaolinbaliu，feitezhixing（B-ALL/LBL，NOS）?chengshuBxibaozhongliu（12gejiazu/zhonglei，49geshiti/leixing）Mature B-cell neoplasms（1）zhongliuqianqihezhongliuxingxiaolinbaxibaozengzhi（2ge）（2）piBxibaolinbaliuhebaixuebing（4ge）（3）linbajiangxibaolinbaliu（1ge）（4）bianyuanqulinbaliu（4ge）（5）lvpaoxinglinbaliu（4ge）（6）pifulvpaozhongxinlinbaliu（1ge）（7）taoxibaolinbaliu（3ge）（8）duoxingBxibaolinbaliudezhuanhua（1ge）（9）daBxibaolinbaliu（18ge）（10）bojitelinbaliu（1ge）（11）KSHV/HHV8xiangguanBxibaolinbazengzhixingjibinghelinbaliu（3ge）（12）yumianyiquexianheshidiaoxiangguandelinbazengzhihelinbaliu（5ge）（13）huoqijinlinbaliu（2ge）diwubanfenleidisiban（xiuding）fenleizhongliuqianqihezhongliuxingxiaolinbaxibaozengzhiPre-neoplastic and neoplastic small lymphocytic proliferationsdankelong B linbaxibaozengduozheng（MBL）?Monoclonal B-cell lymphocytosisxiangtongmanxinglinbaxibaobaixuebing/xiaolinbaxibaolinbaliu（CLL/SLL）?Chronic lymphocytic leukaemia/small lymphocytic lymphomaxiangtongB-PLLbingmingbeishanchu（buzaishiweiyigejibingleixing）Bxibaoyoulinbaxibaobaixuebing（B-PLL）B-prolymphocytic leukemiapiBxibaolinbaliuhebaixuebingSplenic B-cell lymphomas and leukaemiasmaoxibaobaixuebing（HCL）?Hairy cell leukaemiaxiangtongpibianyuanqulinbaliu（SMZL）?Splenic marginal zone lymphomaxiangtongpimimanxinghongsuixiaoBxibaolinbaliu（SDRPL）?Splenic diffuse red pulp small B-cell lymphomaxiangtongpiBxibaolinbaliu/baixuebing，banxianzhuheren（SBLPN）?Splenic B-cell lymphoma/leukaemia with prominent nucleoliweibaokuozainei，wucibingming（disibanbingmingshuyuwei：maoxibaobaixuebingbianyixingheCD5yinxingBxibaoyoulinbaxibaobaixuebing）linbajiangxibaolinbaliuLymphoplasmacytic lymphomalinbajiangxibaolinbaliu（LPL）?Lymphoplasmacytic lymphomaxiangtong【zhu】baokuoliangzhongyaxing：IgM-LPL/WM（zuichangjian，yuezhan95%）：IgM-LPL/Waldenstromjuqiudanbaixuebing（WM，huashijuqiudanbaixuezheng）；feiWMxingLPL（yuezhan5%）。bianyuanqulinbaliuMarginal zone lymphomazhanmoxiangguanlinbazuzhijiewaibianyuanqulinbaliu）（MALT）?Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissuexiangtongyuanfaxingpifubianyuanqulinbaliu（PCMZL）?Primary cutaneous marginal zone lymphomaweidanduliechu（guiruzhanmoxiangguanlinbazuzhijiewaibianyuanqulinbaliu）linbajiebianyuanqulinbaliu（NMZL）?Nodal marginal zone lymphomaxiangtongertong(linbajie)bianyuanqulinbaliu（pNMZL）?Paediatric (nodal) marginal zone lymphomaxiangtong【zhu】jiepobuweibutong，xibaoyichuanxuehejiyintubianpubutong。（1）linbajiebianyuanqulinbaliu（NMZL）hejiewaibianyuanqulinbaliu（EMZL）jiyintubianpubutong。（2）jiewaiMZL（EMZL）changjiandebaokuowei、fei、yanfushuqi、tuoyexian、jiazhuangxian、pifudengbuweideMZL，butongdejiewaiMZLzhijiancunzaixianzhudeyichuanxuechayi。（3）pifuMZLjuyoudutedelinchuangbinglitezheng，qubieyuqitajiewaiMZL（EMZL）erdanliezuoweidulidejibingshitileixing（PCMZL）。（4）ertonglinbajiebianyuanqulinbaliu（pNMZL）shicongNMZLxiadeyigeyaxingshengjichengweiyigedulidejibingshitileixing。lvpaoxinglinbaliuFollicular lymphomayuanweilvpaoxingBxibaozhongliu（ISFN）?In situ follicular B-cell neoplasmyuanweilvpaoxingzhongliu（yuanweilvpaoxingliubian）lvpaoxinglinbaliu（FL）?Follicular lymphomaxiangtongertongxinglvpaoxinglinbaliu?Paediatric-type follicular lymphomaxiangtongshierzhichangxinglvpaoxinglinbaliu?Duodenal-type follicular lymphomaxiangtongpifulvpaozhongxinlinbaliuCutaneous follicle centre lymphomayuanfaxingpifulvpaozhongxinlinbaliu?Primary cutaneous follicle centre lymphomaxiangtongtaoxibaolinbaliuMantle cell lymphomayuanweitaoxibaozhongliu（ISMCN）?In situ mantle cell neoplasmyuanweitaoxibaoliubiantaoxibaolinbaliu（MCL）?Mantle cell lymphomaxiangtongbaixuebingxingfeilinbajiexingtaoxibaolinbaliu（Leukemic non-nodal mantle cell lymphoma，feilinbajieMCL，nnMCL）?xiangtong【zhu】feilinbajieMCL（nnMCL）yuMCLxiangbi，daduomeiyouzhengzhuang，qiyuhouxiangduigenghao，zhuyaoshixueye、gusuihepizangshoulei，henshaohuozhemeiyoulinbajiezhongda。duoxingBxibaolinbaliuzhuanhuaTransformations of indolent B-cell lymphomaduoxingBxibaolinbaliuzhuanhua?Transformations of indolent B-cell lymphomawu【zhu】shoucibaduoxingBxibaolinbaliudegaojibiezhuanhuazuoweiyigedulibufendanlie。daBxibaolinbaliuLarge B-cell lymphomas(LBCL)mimandaBxibaolinbaliu，feitezhixing（NOS）?Diffuse large B-cell lymphoma(DLBCL),NOSxiangtongfuhanTxibao/zuzhixibaodedaBxibaolinbaliu?T-cell/histiocyte-rich large B-cell lymphomaxiangtongmimandaBxibaolinbaliu/gaojibieBxibaolinbaliu，ban MYC he BCL2 zhongpai?DLBCL/HGBL with MYC and BCL2 rearrangementsgaojibieBxibaolinbaliu，ban MYC he BCL2 he/huo BCL6 zhongpaiALKyangxingdaBxibaolinbaliu?ALK-positive large B-cell lymphomaxiangtongdaBxibaolinbaliu，ban IRF4 zhongpai?Lagre B-cell lymphoma with IRF4 rearrangementxiangtonggaojibieBxibaolinbaliu，ban 11q yichang?HGBL with 11q aberrationsBurkittyanglinbaliu，ban 11q yichanglinbaliuyangrouyazhongbing?Lymphomatoid granulomatosisxiangtongEBVyangxingmimandaBxibaolinbaliu?EBV-positive diffuse large B-cell lymphomaEBVyangxingmimandaBxibaolinbaliu，feitezhixing（NOS）mimandaBxibaolinbaliu，banmanxingyanzheng（yumanxingyanzhengxiangguandemimandaBxibaolinbaliu）?Diffuse large B-cell lymphoma associated with chronic inflammationxiangtongxianweidanbai（xianweisu）xiangguandaBxibaolinbaliu?Fibrin-associated large B-cell lymphoma（disibanshiyumanxingyanzhengxiangguandemimandaBxibaolinbaliudeyigeyaxing）tiyeguozaixiangguandaBxibaolinbaliu?Fluid overload-associated large B-cell lymphomawujiangmuxibaolinbaliu?Plasmablastic lymphomaxiangtongyuanfaxingmianyihuomianbuwei（tequanbuwei）daBxibaolinbaliu?Primary large B-cell lymphoma of immune-privileged sites（disibanweidandufenxing，baokuodi4banzhongdeyuanfazhongshushenjingxitong，yuanfaboliti、shiwangmo、zuowandengbuweidemimandaBxibaolinbaliu）yuanfapifumimandaBxibaolinbaliu，tuixing?Primary cutaneous diffuse large B-cell lymphoma,leg typexiangtongxueguanneidaBxibaolinbaliu?Intravascular large B-cell lymphomaxiangtongyuanfazonggedaBxibaolinbaliu?Primary mediastinal large B-cell lymphomaxiangtongzonggehuiqulinbaliu（MGZL）?Mediastinal grey zone lymphomaBxibaolinbaliu，wufafenlei，tezhengjieyuDLBCLhejingdianhuoqijinlinbaliuzhijiangaojibieBxibaolinbaliu，feitezhixing?High-grade B-cell lymphoma(HGBL),NOSxiangtong【zhu】daBxibaolinbaliubaokuoDLBCLfeitezhixingheqita17getedingdaBxibaolinbaliu。（1）DLBCL，NOS?shizuichangjiandeleixing，shiyizuyizhixingdelinbaliu，qixingtai、biaoxingdengjunbumanzumouzhongtedingdaBxibaolinbaliudezhenduanbiaozhun。disibandingyideliangzhongzhuyaoyaxingrengshiyong，jixuqufenGCB/ABC（GCB/feiGCB）yaxing。（2）tiyeguozaixiangguandaBxibaolinbaliu?yeshixinyinrudeleixing，zhuyaobiaoxianweitiqiangshoulei，zuichangjianshixiongmoqiangshoulei，changyoudaozhiyetiguozaidejichujibing（manxingxinshuai、shenshuaijie、ganshuaijie/ganyinghuadeng），duojianyulaonianren，yuhouxiangduijiaohao。yaozhuyi，tayuyuanfaxingshenchuxinglinbaliu（PEL）jiyinbiaodapuheyuhoujunbutong，PELyuhougengcha。PELmuqianguiruKSHV/HHV8xiangguanBxibaolinbazengzhixingjibinghelinbaliuzheyijiazu/zhongleizhong。（3）mianyihuomianbuweideyuanfadaBxibaolinbaliu?yexinbanfenleiyinrudeyigexindezongcheng，shifashengyumianyigongnengzhengchangrenqundeyizuyuanfaqinxixingBxibaolinbaliu，yuanfabuweibaokuozhongshushenjingxitong、bolitishiwangmo、zuowan：yuanfaxingzhongshushenjingxitongDLBCL、yuanfaxingzuowanLBCL、yuanfaxingbolitishiwangmoLBCL。jianglaikenenghuanhuikuochong（biruruxian、pifudeng）。（4）zonggehuiqulinbaliu（MGZL）?juyouyuanfazonggeBxibaolinbaliu（PMBL）hejingdianxinghuoqijinlinbaliu（cHL）dezhongdietezheng，jinfashengyuzongge，shuyudanyishengwuxuetezhengdejibingshiti。BurkittlinbaliuBurkitt lymphomaBurkittlinbaliu（bojitelinbaliu）?Burkitt lymphoma(BL)xiangtong【zhu】bojitelinbaliujiwanggenjuliuxingbingxuebeijinghediliweizhifenweisanzhongliuxingbingxueyaxing：difangxingBL、feidifangxing/sanfaxingBL、mianyiquexianxiangguanBL。kaolvdaoEBVganranzaizaoqifabingjizhizhongqizhongyaozuoyong，jiyufenzitezhengqufenweiliangzhongyaxingqudailiuxingbingxueyaxing，ji：EBVyangxingBLheEBVyinxingBL。KSHV/HHV8xiangguanBxibaolinbazengzhixingjibinghelinbaliuKSHV/HHV8-associated B-cell lymphoid proliferations and lymphomasyuanfaxingshenchuxinglinbaliu（PEL）?Primary effusion lymphomaxiangtongKSHV/HHV8yangxingmimandaBxibaolinbaliu?KSHV/HHV8-positive diffuse large B-cell lymphomaHHV8yangxingmimandaBxibaolinbaliu，feitezhixingKSHV/HHV8yangxingshishengfazhongxinlinbazengzhixingjibing?HSHV/HHV8-positive germinotropic lymphoproliferative disorderHHV8yangxingshishengfazhongxinlinbazengzhixingjibing【zhu】KSHV/HHV8（kaboxirouliuzuozhenbingdu/renleizuozhenbingdu8xing）ganranxiangguandelinbazengzhixingjibingbaokuo：KSHV/HHV8xiangguandeduozhongxinCastlemanbing（KSHV/HHV8-MCD，guidaoBxibaoweizhudezhongliuyangbingbianleibiexia）、yuanfaxingshenchuxinglinbaliu?（Primary effusion lymphoma，PEL）、qiangwaiPEL（EC-PEL）、KSHV/HHV8yangxingmimandaBxibaolinbaliu?（KSHV/HHV8-DLBCL）、KSHV/HHV8yangxingshishengfazhongxinlinbazengzhixingjibing?（KSHV/HHV8-GLPD）。yumianyiquexianheshidiaoxiangguandelinbazengzhihelinbaliuLymphoid proliferations and lymphomas associated with immune deficiency and dysregulationmianyiquexianxiangguanxingsabazuzhizengshengxingjibingmianyiquexian/shidiao（IDD）yinqideguoduzengsheng?Hyperplasias arising in immune deficiency/dysregulationweilieru，disibanbubaokuozainei，disibanbaokuofei（zuzhi）pohuaixingyizhihoulinbazengzhixingjibing（feipohuaixingPTLD）dengmianyiquexian/shidiaoyinqideduoxingxinglinbazengzhi（duoxingxinglinbazuzhizengzhixingjibing）?Polymorphic lymphoproliferative disorders arising in immune deficiency/dysregulationweilieru（disibanbubaokuozainei，baokuoduoxingxingyizhihoulinbazuzhizengzhixingjibing（duoxingxingPTLD）、qitayiyuanxingmianyiquexianxiangguandelinbazuzhizengshengxingjibingdeng）EBVyangxingpifuzhanmokuiyang?EBV-positive mucocutaneous ulcer(EBVMCU)xiangtongmianyiquexian/shidiaoyinqidelinbaliu?Lymphoma arising in immune deficiency/dysregulationweilieru，disibanbubaokuozaineidisibanbaokuodanxingxingyizhihoulinbazuzhizengzhixingjibing（danxingxingPTLD）、jingdianxinghuoqijinlinbaliuyangyizhihoulinbazuzhizengzhixingjibing、HIVganranxiangguanlinbaliudeng）mianyixiangguanlinbayangzengshenghelinbaliudexiantianxingcuowu（xiantianxingmianyiquexianxiangguanlinbazengzhihelinbaliu，mianyichushengcuowuxiangguandelinbazengzhihelinbaliu）?Inborn error of immunity-associated lymphoid proliferations and lymphomaslinbazengzhixingjibingxiangguan，banyuanfamianyijibing（yuyuanfaxingmianyijibing/quexianxiangguandelinbazengzhixingjibing）【zhu】mianyiquexian/shidiao，mianyiquexianbing（immunodeficiency diseases，IDD）shiyizuyouyumianyixitongfayubuquanhuozaoshousunhaisuozhidemianyigongnengquexianyinqidejibing，youerzhongleixing：①yuanfaxingmianyiquexianbing（xiantianxingmianyiquexianbing），yuyichuanyouguan，duofashengzaiyingyouer。②jifaxingmianyiquexianbing（huodexingmianyiquexianbing），kefashengzairenhenianling，duoyinyanzhongganranyouqishizhijieqinfanmianyixitongdeganran、exingzhongliu、yingyongmianyiyizhiji、fangliaohualiaodengyuanyinyinqi。yupeixitubianxiangguandeyuanfaxingmianyiquexianbeiguojimianyixuehuilianhehuizhongxinmingmingwei“mianyichushengcuowu”（inborn error of immunity,IEI）（jiwangchengweixiantianxingmianyiquexian），xinbanWHO-HAEM5fenleicaiyonggaishuyumingcheng。huoqijinlinbaliuHodgkin lymphmajingdianxinghuoqijinlinbaliu?Classic Hodgkin lymphma（cHL）xiangtongjiejiexinglinbaxibaoweizhuxinghuoqijinlinbaliu?Nodular lymphocyte predominant Hodgkin lymphma（NLPHL）xiangtong【zhu】huoqijinlinbaliuzaijiubanzhongzuoweidulideleibie（category），Hodgkinxibao（RSxibaodedanhebianyixing）heReed-Sternbergxibao（lisixibao，RSxibao，biaoxianweiduohejuxibao）qiyuanyushengfazhongxindeBxibao，bingkaolvdaodangdaidezhiliaomoshi，bahuoqijinlinbaliudandufenchulaideyuhouyiyibuda，yincixinbanfenleibahuoqijinlinbaliubeiguidaochengshuBxibaozhongliuleibie（category）xia，zuoweichengshuBxibaozhongliudeyigejiazu/zhonglei（family/class）。linbaxibaoweizhuxinghuoqijinlinbaliu（LPHL），zhanhuoqijinlinbaliu5%-6%，dabufenzaidibeijingxiakejiandaojiejieyangjiegou，beijingweixiaolinbaxibaojujimijichengjiejiefenbu，xiangsiyulvpaolinbaliu，yechengweijiejiexinglinbaxibaoweizhuxingHL（NLPHL）。jinyoujishaoshuzhenduanxingdeRSxibao，qiechangweiyileichengwei“L＆H”RSxibao，yechengweiHLdexibaoxibaohe/huozuzhixibaoyaxing，yechengwei“baomihuaxibao”。kefashengzairenhenianling，zhongweifabingnianling60sui，nanxingduojian，changqinfanlinbajie，yuhoujiaohao。mianyizuhuaranseCD30（-），biaodaBxibaokangyuan（CD20+，CD15-）。kehouqifufa，kezhuanhuaweiBxibaoNHL。jingdianxinghuoqijinlinbaliu（CHL），juyouxingtaixuedianxingdezhenduanxingRSxibaojiqidanhebianyixing（huoqijinxibao），liuxibaotezhengxingbiaodaCD30+，changbiaodaCD15+，CE20-。baokuosigeyaxing：jiejieyinghuaxingcHL（NSCHL）、fuyulinbaxibaoxingcHL（LRCHL）、hunhexibaoxingcHL（MCHL）、linbaxibaoxiaojianxingcHL（LDCHL）。jiangxibaozhongliujiqitajuyoufudanbaidejibing（12geshiti/leixing）Plasma cell neoplasms and other diseases with paraproteinsdiwubanfenleidisiban（xiuding）fenleidankelongbingzhongqiudanbaibingMonoclonal gammopathieslengningjisubing（CAD）?Cold agglutinin diseasewuyiyiweimingdeIgMdankelongbingzhongqiudanbaibing?IgM monoclonal gammopathy of undetermined significance（IgM MGUS）xiangtongyiyiweimingdefeiIgMdankelongbingzhongqiudanbaibing?Non-IgM MGUSxiangtongjuyoushenzangyiyidedankelongbingzhongqiudanbaibing?Monoclonal gammopathy of renal significance(MGRS)weilie rudankelongmianyiqiudanbaichenjidejibingDiseases with monoclonal immunoglobulin depositionmianyiqiudanbaixiangguan（AL）dianfenyangbianxing?Immunoglobulin-related(AL) amyloidosisyuanfaxing（qinglian）dianfenyangbianxingdankelongmianyiqiudanbaichenjibing?Monoclonal immunoglobulin deposition diseaseqinglianhezhonglianchenjibingzhonglianbingHeavy chain diseases（HCD）μ（Mu）zhonglianbing?Mu heavy chain diseasexiangtongγ（Gamma）zhonglianbing?Gamma heavy chain diseasexiangtongα（Alpha）zhonglianbing?Alpha heavy chain diseasexiangtongjiangxibaozhongliuPlasma cell neoplasmsjiangxibaoliu?Plasmacytomaxiangtongjiangxibaogusuiliu?Plasma cell myeloma/multiple myelomaxiangtongfuzhongliuzonghezhengxiangguandejiangxibaozhongliu?Plasma cell neoplasms with associated paraneoplastic syndromePOEMS zonghezhengTEMPI zonghezhengAESOP zonghezheng（adenopathy and extensive skin patch overlying a plasmacytoma，linbajiezhongdaheguangfanpifubankuaibanjiangxibaoliu）xiangtong（danAESOP zonghezhengyiqianbubaokuozainei）TheNKxibaolinbazengzhixingjibinghezhongliuT-cell and NK-cell lymphoid proliferations and lymphomas（39geshiti/leixing）Txibaoweizhuzhongliuyangbingbian（3geshiti/leixing）Tumor-like lesions with T-cell predominancediwubanfenleidisiban（xiuding）fenleijuchi-tengbenbing?Kikuchi-Fujimoto disease(KFD)wuduoxing T linbamuxibaoxingzengzhi?Indolent T-lymphoblastic proliferation(ITLP)wuzishenmianyixinglinbazengzhizonghezheng?Autoimmune lymphoproliferative syndrome(ALPS)wu【zhu】Txibaoweizhuzhongliuyangbingbianxidiwubanxinyinrudefenlei。qiantiTxibaozhongliu（2geshiti/leixing）Precursor T-cell neoplasmsji：yuanshiTlinbaxibaobaixuebing/linbaliu（Tlinbaxibaobaixuebing/linbaliu，Tlinbamuxibaobaixuebing/linbaliu，T-lymphoblastic leukaemias/lymphomas，T-ALL/LBL）diwubanfenleidisiban（xiuding）fenleiTlinbamuxibaobaixuebing/linbaliu，feitezhixing?T-lymphoblastic leukaemia/lymphoma,NOS（T-ALL/LBL，NOS）Tlinbamuxibaobaixuebing/linbaliuzaoqiTqiantilinbamuxibaobaixuebing/linbaliu?Early T-precursor ALL/LBL (ETP-ALL/LBL)zaoqiTqiantilinbaxibaobaixuebing（yishanchu）NKlinbamuxibaobaixuebing/linbaliu（yuanshiNKxibaobaixuebing/linbaliu）【zhu】NKlinbamuxibaobaixuebing/linbaliuzaidisibanfenleizhongzuoweilinshijibingleixing，youyuquefamingquedekekaodezhenduanbiaozhunyijixiangguandexingtaixuehemianyibiaoxingtezheng，diwubanfenleizhongweidanduliechu。chengshuTxibaoheNKxibaozhongliu（9gejiazu/zhonglei，34geshiti/leixing）Mature T-cell and NK-cell neoplasms（1）chengshuTxibaoheNKxibaobaixuebing（6ge）；（2）yuanfaxingpifuTxibaolinbaliu（9ge）；（3）changdaoTxibaoheNKxibaolinbazengzhihelinbaliu（5ge）；（4）ganpiTxibaolinbaliu（1ge）；（5）jianbianxingdaxibaolinbaliu（3ge）；（6）linbajieTlvpaofuzhuxibaolinbaliu（3ge）；（7）qitawaizhouTxibaolinbaliu（1ge）；（8）EBVyangxingNK/Txibaolinbaliu（2ge）；（9）ertongEBVyangxingTxibaoheNKxibaolinbazengzhihelinbaliu（4ge）【zhu】chengshuTxibaoheNKxibaozhongliugenjuxibaoqiyuan/fenhuazhuangtai、linchuangtezheng、jibingbuwei/weizhi、xibaoxingtaixuedengqufenwei9gejiazu/zhonglei，gong34gejibingshiti/leixing。daduoshuTxibao、NKxibaozhongliukeguirugezixiangyingdeTxibao、NKxibaopuxi，danyoudejibingleixingbaokuoNKxibao、Txibao、hunhehuobuquedingdezhongliubiaoxing，TxibaoheNkxibaoqiyuandequfennanyuquedinghuobuqingchu，yincidiwubanfenleizhongmeiyoujiandandifenweiTxibaozhongliuheNKxibaolianglei，biruchengshuTxibaoheNKxibaobaixuebing、EBV-yangxingjiexingTxibaoheNKxibaolinbaliu、jiewaiNK/Txibaolinbaliudeng。diwubanfenleidisiban（xiuding）fenleichengshuTxibaoheNKxibaobaixuebingMature T-cell and NK-cell leukaemiasT-youlinbaxibaobaixuebing（T-PLL）?T-prolymphocytic leukaemiaxiangtongTdakelilinbaxibaobaixuebing（T-LGLL）?T-large granular lymphocytic leukaemiaTxibao（dakeli）linbaxibaobaixuebingNKdakelilinbaxibaobaixuebing（NK-LGLL）?NK-large granular lymphocytic leukaemiaNKxibaomanxinglinbazengshengxingjibingchengren T xibaobaixuebing/linbaliu（ATLL）?Adult T-cell leukaemia/lymphomaxiangtongSezaryzonghezheng（saizhalizonghezheng，SS）?Sézary syndromexiangtongqinxixing NK xibaobaixuebing（ANKL）?Aggressive NK-cell leukaemiaxiangtongyuanfaxingpifuTxibaolinbaliuPrimary cutaneous T-cell lymphomasyuanfaxingpifu CD4 yangxingxiao /zhongT xibaolinbazengzhixingjibing?Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorderxiangtongyuanfaxingpifuzhiduan CD8 yangxinglinbazengzhixingjibing?Primary cutaneous acral CD8-positive lymphoproliferative disorderyuanfaxingpifuzhiduan CD8 yangxing T xibaolinbaliuzuoyangrouyazhong?Mycosis fungoides(MF)xiangtongyuanfaxingpifuCD30yangxingTxibaolinbazengzhixingjibing：linbaliuyangqiuzhenbing?Primary cutaneous CD30-positive T-cell LPD:Lymphomatoid papulosisxiangtongyuanfaxingpifuCD30yangxingTxibaolinbazengzhixingjibing：yuanfaxingpifujianbianxingdaxibaolinbaliu?Primary cutaneous CD30-positive T-cell LPD:Primary cutaneous ALCLxiangtongpixiazhimoyanyangTxibaolinbaliu?Subcutaneous panniculitis-like T-cell lymphomaxiangtongyuanfaxingpifu γ/δ T xibaolinbaliu?Primary cutaneous gamma/delta T-cell lymphomaxiangtongyuanfaxingpifuCD8yangxingqinxixingshibiaopixibaoduxingTxibaolinbaliu?Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphomaxiangtongyuanfaxingpifuwaizhouTxibaolinbaliu，feitezhixing（NOS）?Primary cutaneous peripheral T-cell LPD,NOSwu【zhu】yuanfaxingpifuTxibaolinbaliu（CTCL）shixinbanfenleizhongchengshuT/NKxibaozhongliuleibiexiadeyigezhuanmendejiazu/zhonglei，baokuo9gejibingshiti/leixing。changdaoTxibaoheNKxibaolinbazengzhihelinbaliuIntestinal T-cell and NK-cell Lymphoid proliferations and lymphomasweichangdaoduoxingTxibaolinbaliu?Indolent T-cell lymphoma of the gastrointestinal tractweichangdaoduoxingTxibaolinbazengzhixingjibingweichangdaoduoxing NK xibaolinbazengzhixingjibing?Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tractwuchangbingxiangguanTxibaolinbaliu?Enteropathy-associated T-cell lymphomaxiangtongdanxingxingshishangpixingchangdao T xibaolinbaliu?Monomorhpic epitheliotropic intestinal T-cell lymphomaxiangtongchang daoT xibaolinbaliu，feitezhixing（NOS）?Intestinal T-cell lymphoma ,NOSxiangtong【zhu】weichangdao（GI）duoxingTxibaolinbazengzhixingjibingxinmingmingweiweichangdaoduoxingTxibaolinbaliu，mingmingcong“linbazengzhixingjibing”dao“linbaliu”dezhuanbian，shijiyuqigaofashenglvhejibingdebosanxing，danlinchuangguochengrengranmanchang，suoyirengbaoliu“duoxing”zheyixiandingci。weichangdaoduoxingNKxibaolinbazengzhixingjibing（iNKLPD,indolent NK-cell lymphoproliferative disorder）shixinzengleixing，jiwangrenweishiyizhongfanyingxingguochengerchengweilinbaliuyangweibinghuoNKxibaochangbing，danzuijindefaxianzhichitadezhongliuxingtezheng，yincixinyinruzuoweiyigedulidejibingshiti/leixing。ganpiTxibaolinbaliuHepatosplenic T-cell lymphomaganpiTxibaolinbaliu（HSTCL）?Hepatosplenic T-cell lymphomaxiangtongjianbianxingdaxibaolinbaliuAnaplastic large cell lymphomaALK-yangxingjianbianxingdaxibaolinbaliu?ALK-positive anaplastic large cell lymphoma（ALK+ALCL）jianbianxingdaxibaolinbaliu, ALK-yangxingALK-yinxingjianbianxingdaxibaolinbaliu?ALK-negative anaplastic large cell lymphoma（ALK-ALCL）jianbianxingdaxibaolinbaliu, ALK-yinxingrufangzhiruwuxiangguanjianbianxingdaxibaolinbaliu?Breast implant-associated anaplastic large cell lymphoma（BIA-ALCL）xiangtong【zhu】jianzhibianxingdaxibaolinbaliu（ALCL）jiazubaokuo3gejibingshiti/leixing：ALK+ALCL、ALK-ALCL、BIA-ALCL。junweichengshuTxibaolinbaliu，CD30qiangbiaoda，tongchangbubiaodaTxibiaozhiwu。yuanfaxingpifuALCLmeiyouguizaigaijiazuxia，ershiguileidaolingyijiazu“yuanfaxingpifuTxibaolinbazengzhihelinbaliu”xia，qiyuquanshenxingALK-ALCLxiangbiyuhougengjia。rufangzhiruwuxiangguandeALCLshiyizhongbutongyuqitaALK-ALCLdejibingleixing，shiyizhongfeiqinruxingzhongliu，yucucaobiaomianrufangzhiruwuxiangguan，linchuangyuhouxiangduijiaohao，danruguoqinfanlinjinjiegouzeyuhoubiancha。linbajieTlvpaofuzhu(TFH)xibaolinbaliuNodal T-follicular helper(TFH) cell lymphomalinbajieTFHxibaolinbaliu，xueguanmianyimuxibaoxing?Nodal TFH cell lymphoma ,angioimmunoblastic-type（nTFHL-AI）xueguanmianyimuxibaoxingTxibaolinbaliu（AITL）linbajieTFHxibaolinbaliu，lvpaoxing?Nodal TFH cell lymphoma ,follicular-type（nTFHL-F）lvpaoxingTxibaolinbaliulinbajieTFHxibaolinbaliu，feitezhixing?Nodal TFH cell lymphoma ,NOS（nTFHL-NOS）juyouTFHbiaoxingdejiexingwaizhouTxibaolinbaliu【zhu】linbajielvpaofuzhuxingTxibaolinbaliu（nTFHL）jiazubaokuo3gejibingshiti/leixing，junxilinbajieTxibaolinbaliu，juyouTFH（lvpaofuzhuxingTxibao）debiaoxinghejiyinbiaodatezheng。nTFHL-AI，angioimmunoblastic-type duiyingyuyiqiande“xueguanmianyimuxibaoxingTxibaolinbaliu”nTFHL-F，ollicular-type duiyuyingyuyiqiande“lvpaoTxibaolinbaliu”nTFHL-NOS duiyingyuyiqiande“juyouTFHbiaoxingdewaizhouTxibaolinbaliu”qitawaizhouTxibaolinbaliuwaizhouTxibaolinbaliu，feitezhixing（NOS）?Peripheral T-cell lymphoma,not otherwise specified(NOS)xiangtong【zhu】PTCL-NOSshiyizuyizhixinghenqiangdejibing，shipaichuxingzhenduan，tebieyaojianbienTFHL。EBVyangxingNK/TxibaolinbaliuEBV-positive NK/T-cell lymphomasEBVyangxingjiexingTxibaoheNKxibaolinbaliu?EBV-positive nodal T- and NK-cell lymphomawujiewaiNK/Txibaolinbaliu（ENKTL）?Extranodal NK/T-cell lymphomajiewaiNK/Txibaolinbaliu，bixing【zhu】jiewaiNK/Txibaolinbaliu（ENKTL）kefashengzaibutongdejiewaibuwei，yincishanchujiubanzhongdexiandingci“bixing”。EBVyangxingjiexingTxibaoheNKxibaolinbaliujiwangbeiguiruPTCL-NOSxiadeyigeyaxing，zaixinbanfenleizhongzuoweiyigedulidejibingshiti/leixing，zhuyaofashengzaidongyarenzhong，yuhoucha。ertongEBVyangxingTxibaoheNKxibaolinbazengzhihelinbaliuEBV-positive T- and NK-cell lymphoid proliferations and lymphomas of childhoodyanzhongwenchongdingyaoguomin?Severe mosquito bite allergyxiangtongzhongdouyangshuizuobinglinbazengzhixingjibing?Hydroa vacciniforme LPD(HVLPD)zhongdouyangshuizuobingyang（Hydroa vacciniforme-like）linbazengzhixingjibingxitongxingmanxinghuodongxingEBVjibing（xitongxingCAEBVD）?Systemic chronic active EBV diseaseTxibaoheNKxibaoleixingdemanxinghuodongxingEBVganran，xitongxingertongxitongxingEBVyangxingTxibaolinbaliu?Systemic EBV-positive T-cell lymphoma of childhoodxiangtong【zhu】（1）manxinghuodongxingEBVbing（CAEBVD）：baokuojuzaozhengzhuanghe/huoduoxingxingshideyanzhongwenchongdingyaoguomin?heHVLPDjingdianxing?，yijiquanshenxingjibingHVLPDquanshenxing?hexitongxingCAEBVD?。（2）ertongxitongxingEBVyangxingTxibaolinbaliu?Hydroa vacciniforme（zhongdouyangshuizuobing，douchuangyangshuizuobing）linbazuzhidejianzhiyuanxingzhongliuStroma-derived neoplasms of lymphoid tissues（7geshiti/leixing）diwubanfenleidisiban（xiuding）fenleijianzhishutuxibaozhongliuMesenchymal dendritic cell neoplasmslvpaoshutuxibaorouliu?Follicualr dendritic cell sarcomaxiangtongEBV-yangxingyanxinglvpaoshutuxibaorouliu?EBV-positive inflammatory follicular dendritic cell sarcomayanxingjialiuyanglvpao/chengxianweixibaoshutuxibaorouliuxianweimuxibaowangzhuangxibaoliu?Fibroblastic reticular cell tumorxiangtongjixianweimuxibaoliuMyofibroblastic tumourjieneizhalanzhuangjixianweimuxibaoliu?Intranodal palisaded myofibroblastomawupiteyixingxueguanjianzhizhongliuSpleen-specific vascular-stromal tumourspixueguanjianzhiliuSplenic vascular-stromal tumourspizuoanxibaoxueguanliu?Littoral cell angiomawupicuogouliu?Splenic hamartomawupiyinghuaxingxueguanliuyangjiejiexingzhuanhua?Sclerosing angiomatoid nodular transformation of spleenwu【zhu】1、linbazuzhijianzhiyuanxingzhongliudemouxieleixingshilinbajiehuopizangsuoteyoude，guirubenfenleitixizhong。feilinbajiehepizangteyixingderuanzuzhizhongliu（biruxueguanliu、xueguanrouliu、linbaguanjiliu、kaboxirouliudeng）guidao2020niandiwubanWHOguheruanzuzhizhongliufenleizhong。2、linbazuzhijianzhi（jizhi）laiyuanzhongliushidiwubanxinyinrudefenlei，gaileibiexiabaokuosandalei：（1）jianzhishutuxibaozhongliu：cong“zuzhixibaoheshutuxibaozhongliu”leibiezhongyiguolaidelvpaoshutuxibaozhongliu（?he?）hechengxianweiwangzhuangxibaozhongliu?guiruzheyixinleibiemingxia（yinweilvpaoshutuxibaobingfeiyuanzizaoxueganxibao，ershijianzhilaiyuan）。lingwai，EBVyangxingyanxinglvpaoshutuxibaorouliu?youyujuyoudutedelinchuangbinglitezheng，conglvpaoshutuxibaorouliu?zhongdanliechulaizuoweidulidejibingleixing。（2）jixianweimuxibaoliu，xilinbajieteyixingjianzhizhongliu（linbajieneizhalanzhuangjixianweimuxibaoliu?）。（3）piteyixingjianzhizhongliu，baokuo：pizuoanxibaoxueguanliu?、picuogouliu?、piyinghuaxingxueguanliuyangjiejiexingzhuanhua?）。shutuxibaohezuzhixibaozhongliuDendritic cell and histiocytic neoplasms（11geshiti/leixing）diwubandisiban（xiuding）fenleijiangxibaoyangshutuxibaozhongliuPlasmacytoid dendritic cell neoplasmsyusuixizhongliuxiangguandechengshujiangxibaoyangshutuxibaozengzhiMature plasmacytoid dendritic cell proliferation associated with myeloid neoplasmwumuxibaoxingjiangxibaoyangshutuxibaozhongliuBlastic plasmacytoid dendritic cell neoplasmwulanggehansixibaoheqitashutuxibaozhongliuLangerhans cell and other dendritic cell neoplasmslanggehansixibaozhongliuLangerhans cells neoplasmslanggehansixibaozuzhixibaozengshengzhengLangerhans cell histiocytosisxiangtonglanggehansixibaorouliuLangerhans cell sarcomaxiangtongqitashutuxibaozhongliuOther dendritic cell neoplasmsweidingleishutuxibaoliuIndeterminate dendritic cell tumourxiangtong（weiquedingshutuxibaozhongliu）zhituzhuangshutuxibaorouliuInterdigitating dendritic cell sarcomaxiangtong（jiaozhishutuxibaorouliu）zuzhixibaozhongliuHistiocytic neoplasmsyounianhuangserouyazhongJuvenile xanthogranulomaxiangtong（bosanxingyounianhuangserouyazhong）Erdheim-Chesterbing（ECD）Erdheim-Chester diseasexiangtongRosai-Dorfmanbing（RDD）Rosai-Dorfman diseasewuALKyangxingzuzhixibaozengshengzhengALK-positive histiocytosiswuzuzhixibaorouliuHistiocytic sarcomaxiangtong【zhu】zuzhixibao/shutuxibaozhongliuzaixinbanfenleitixizhongdingweiyusuixizhongliuzhihou，tongchangrenweitamenqiyuanyuchangjiandesuixizuxibao（suixizuxibaochanshengdanhexibao/zuzhixibao/shutuxibaopuxi）。disibanzuzhixibao/shutuxibaozhongliuxiade“lvpaoshutuxibaorouliu”、“chengxianwei（xianweimuxibao）wangzhuangxibaozhongliu”，kaolvdaoshiyoulinbajizhixibaochanshengdezhongliu，diwubanfenleijiangqicongzuzhixibao/shutuxibaozhongliuzhongfenchulaiguirudaolinxizhongliu“linbazuzhijianzhiyuanxingzhongliu”xia。cankaowenxian：（1）The 5th edition of the World Health Organization Classifification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia(2022) 36:1703-1719.https://doi.org/10.1038/s41375-022-01613-1.（2）The 5th edition of the World Health Organization Classifification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia(2022) 36:1720-1748.https://doi.org/10.1038/s41375-022-01620-2.xinnengyuanqicheweilaifazhanzenmeyang？2024-01-09 12:15·longzuoqu#xinnengyuanqiche# #xinnengyuanqicheweilaifazhanzenmeyang?#1、xinnengyuanqichedingyicaiyongfeichangguicheyongranliaozuoweidonglilaiyuan(huoshiyongchangguidecheyongranliao、caiyongxinxingchezaidonglizhuangzhi)，juyouxinjiegouxinjishudeqiche。2、xinnengyuanyoushinengyuanliyonglvgenggao，tanpaifanggengdi，shiyongchengbengengdi，xingshiwending，biansuxiangduoshushixingxinglunjiansuqi，wuhuandangchongji，meiyouxianhao。3、xinnengyuanqichefazhanzhuyaofenweilianggejieduan:diyijieduanshiyihunhedongliqicheweizhu，ranliaodianchichedengxinnengyuanqicheweifudefazhanfangxiang，kaituoxinnengyuanqicheshichang;dierjieduanshizaichundiandongqichejishuchengshudejichushang，chundiandongqichezhubutidaihunhedongliqiche，heranliaodianchiqichewanquanzhanjuxinnengyuanqicheshichang，shixianlingpaifangdejieduan。4、xinnengyuanqichefazhanlishi■ xinnengyuanqichedanshengyu1834nian，bineiranjiqichezaoliaobangeduoshiji，shijiushijimozhiershishijichushidiandongchefazhandehuangjinshiqi，danshouxianyujishushuipingheshehuihuanjing，dangshidediandongchewufashixianchangjulijigaosuxingshi;ershishijichudaoershishiji70niandai，suizhuoshiyoudedaliangkaicaiheneiranjijishudebuduanfazhan，erdianchijishuhexuhanglichengshizhongwufashixiantupo，diandongchefazhanxianruchenji;■ershishiji90niandaikaishi，zailiangcishiyouweijijikongqiwurandedahuanjingxia，renmenzhongxinjujiaoyidiandongqicheweishoudexinnengyuanqiche，jinruershiyishijihou，diandongqichejishuchixutupo，xinnengyuanqichezaiduchengweiditanjingjidamuxiadebiranxuanze，yigexinnengyuanqichefazhandexinshidaijiucilailin!5、xinnengyuanqichefazhanqushiquanqiuqicheshichangchengxianjiasudiandonghuaqushi，xinnengyuanqichexiaoshouzhanbiyuanchaoyuqi，2022nianxiaoliang1125.8wanliang，tongbidafuzengchang67.1%，shichangshentoulvyou2020niande4.2%zengchangzhi2023de14.2%zhongguoxinnengyuanqichexiaoliangchangnianbaochiquanqiuzongliang40%yishang，2022nianxiaoliang688.7wan，tongbizengchang336.4wanliang，zhanquanqiuduanzengxiaoliangde77%，jinnian1-10yue，woguoxinnengyuanqichexiaoshou728wanliang，tongbizengchang37.8%，shichangshentoulvda30.4%，yujiquannianshentoulvjiangdadao36%，quanmianyinlingxinnengyuanqichefazhan，quanqiuxinnengyuanqicheshentoulvkuaisuzengchang。6、qicheqiyeneibuxianzhufenhua:diandonghuazhuanxingbeijingxia，chuantongcheqijixujiannanzhuanshen，guochanzizhupinpaigouchengjingzhengzhuti，zaochexinshilirengzaijijitansuotupo。7、xinnengyuanqichehexinbujianweidonglidianchi、qudongdianji、kongzhizhuangzhi8、genjutigongdonglifangshibutong，kejiangxinnengyuanqichefenweiyixiasangeleibiehunhedongliqiche(48V、HEV、PHEV )chundiandongqiche(EV)ranliaodianchiqiche(FCEV)
最(窜耻颈)终(窜丑辞苍驳)，父(贵耻)亲(蚕颈苍)因(驰颈苍)酒(闯颈耻)后(贬辞耻)驾(闯颈补)驶(厂丑颈)被(叠别颈)依(驰颈)法(贵补)处(颁丑耻)以(驰颈)驾(闯颈补)驶(厂丑颈)证(窜丑别苍驳)暂(窜补苍)扣(碍辞耻)6个(骋别)月(驰耻别)、记(闯颈)12分(贵别苍)，罚(贵补)款(碍耻补苍)1000元(驰耻补苍)的(顿别)处(颁丑耻)罚(贵补)。儿(贰谤)子(窜颈)最(窜耻颈)终(窜丑辞苍驳)血(齿耻别)检(闯颈补苍)值(窜丑颈)为(奥别颈)90尘驳/100尘濒，达(顿补)到(顿补辞)醉(窜耻颈)驾(闯颈补)标(叠颈补辞)准(窜丑耻苍)，案(础苍)件(闯颈补苍)还(贬耻补苍)在(窜补颈)进(闯颈苍)一(驰颈)步(叠耻)办(叠补苍)理(尝颈)中(窜丑辞苍驳)。
外卖小哥不买雅迪、爱玛电动车的原因：从事外卖职业的都是低收入人群，家庭经济条件不好。很多小哥在买电动车的时候会关注价格，而雅迪、爱玛等知名品牌生产的电动车售价较高。因为这两个品牌每年在广告上需要花费巨额投资，邀请明星做品牌代言人，新车型发布花费巨资做广告宣传。而这些广告费用会均摊到生产的每辆电动车上，导致品牌溢价较高，车辆性价比不高，好多外卖小哥想买雅迪或爱玛的电动车，因为较高的售价打起了退堂鼓。1914年，一个名叫菲得里克·柯洛普的美国人，本职是一家石油公司的所谓专家，他奉命来到中国华北，作深入的地质勘查，寻找哪里有石油可以开采。宅宅网在线电影观看神奇影院手机版补辫辫下载冲多特软件
回头看我认为这个问题很严重 萨默斯说除了考虑量化宽松的刺激作用我们还需要关注量化宽松对资产负债表债务期限的影响